Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and Safety of the <scp>TYK2</scp>/<scp>JAK1</scp> Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase <scp>IIb</scp> Randomized Controlled Trial
PaperCitations, authors & open-access status
Efficacy and Safety of the <scp>TYK2</scp>/<scp>JAK1</scp> Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase <scp>IIb</scp> Randomized Controlled Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 65 citations, 2023 year and hybrid oa status.
65
Citations
2023
Year
hybrid
OA Status